“Receiving ATMP classification is another significant milestone toward bringing OCU400 to the market in Europe,” said Dr. Shankar Musunuri, Ocugen’s Chairman, CEO, and Co-founder.

In the field of cell-based therapies, the Microsart® ATMP Sterile Release Kit stands out as an essential tool for ensuring the safety and efficacy of Advanced Therapy Medicinal Products (ATMPs). This ...

Micron Technology has launched the bidding process to secure a construction partner for the second phase of its ATMP project, ...

The Erling-Persson Foundation is donating SEK 8 million to KI researcher Johan Ericson to fund the verification of his ATMP ...

Approximately 3,00,000 jobs are expected in chip semiconductor fabrication, with an additional 2,00,000 roles in assembly, ...

This is the second part of our series, "The ATMP Manufacturer's Guide to Commercialisation and cGMP Compliance". The first article in the ATMP series focused on the standardised production ...

This semiconductor Assembly, Testing, Marking and Packaging (ATMP) facility is being constructed by Tata Projects for Micron. Giving details about the progress, a top executive of Tata Projects ...

In June 2023, the Gujarat government signed a $2.75 billion agreement with Micron for this project. Once operational, the facility is expected to create 5,000 direct jobs and 15,000 indirect jobs ...

Ocugen (NASDAQ:OCGN) said it has received a positive opinion from European Medicines Agency regulators for Advanced Therapy Medicinal Product classification for its gene therapy OCU400 in the ...

There is no Morningstar’s Analysis data available. We sell different types of products and services to both investment professionals and individual investors. These products and services are ...

Construction of US-based Micron Technology's semiconductor assembly and test facility at Sanand, near Ahmedabad, is set to be completed by December 2025. Tata Projects, overseeing the project, has ...